Preparation of (4S,5R)-2-(4-methoxyphenyl)-4-phenyl-3,5-oxazolidinedicarboxylic acid 3-tert-butyl ester_Industrial additives

Background and overview[1]

(4S,5R)-2-(4-Methoxyphenyl)-4-phenyl-3,5-oxazolidinedicarboxylic acid 3-tert-butyl ester is a pharmaceutical intermediate, which can be made from ( 2′R,3′S)-phenylisoserine methyl ester and p-toluic acid were prepared in three steps. There are reports in the literature that (4S,5R)-2-(4-methoxyphenyl)-4-phenyl-3,5-oxazolidinedicarboxylic acid 3-tert-butyl ester can be used to prepare an anti-tumor activity A novel taxane antitumor compound derived from the 2′-derivatized side chain of docetaxel.

Preparation[1]

Step 1. Synthesis of (2′R,3′S)-N-Boc-phenylisoserine methyl ester 6

Add 50mmol of (Boc)2O dissolved in CH2Cl2 with CH2Cl 2/H2O dissolved (2′R,3′S)-phenylisoserine methyl ester 50mmol and 3.58g potassium hydroxide solution, react at room temperature Carry out, TLC monitors that after the reaction is complete, add H2O to the reaction solution, let it stand for layering, separate the organic phase, and use CH2Cl2 for the aqueous phase. Extract, combine the organic phases, wash with water, and dry with anhydrous MgSO4. The solvent was removed to obtain a crude product, which was recrystallized to obtain (2′R,3′S)-N-Boc-phenylisoserine methyl ester with a yield of 93.2%.

Step 2, synthesis of phenyloxazoline carboxylic acid methyl ester compound 7

Dissolve 46.4 mmol of compound 6, 51 mmol of p-methoxybenzaldehyde and 0.1 g of pyridinium p-toluenesulfonate in toluene and reflux. TLC monitors that the reaction is complete and then cools to room temperature and removes the solvent to obtain compound 7.

Step 3. Synthesis of (4S,5R)-2-(4-methoxyphenyl)-4-phenyl-3,5-oxazolidinedicarboxylic acid 3-tert-butyl ester 8

Dissolve the above product 7 with MeOH, add dilute NaOH, stir at room temperature, remove MeOH after monitoring the reaction with TLC, and dissolve and dilute the residue with AcOEt/H2O, and leave to separate. Add AcOEt to the aqueous phase and adjust the pH to acidic with dilute hydrochloric acid. The mixture was allowed to stand and separated into layers, and the organic phase was separated. The aqueous phase was extracted with AcOEt. The organic phases were combined, washed with water, and dried with anhydrous MgSO4. The solvent was removed to obtain phenyloxazoline carboxylic acid 8. , the total yield of the two steps is 92%, m.p.132-133℃. 1HNMR(MHz,CDCl3)δ7.50-7.31(m,7H),6.94(d,J=8.6Hz,2H),6.41(s,1H ),5.42(s,1H),4.64(d,J=4.2Hz,1H),3.83(s,3H).13CNMR(100MHz,CDCl3)δ172.73,160.44,151.71,128.89,128.33,128.17,126.32,114.00, 92.44,82.57,81.14,63.68,55.32,27.82.

Main reference materials

[1][Chinese invention] CN201811188548.8 A docetaxel-1,2,3,-triazole compound and its synthesis process and application

TAG: (4S,5R)-2-(4-methoxyphenyl)-4-phenyl-3,5-oxazolidinedicarboxylic acid 3-tert-butyl ester, pharmaceutical intermediate, (2 ′R,3′S)-phenylisoserine methyl ester

Call Us

18962365658

Email: edisonzhao@51qiguang.com

Working hours: Monday to Friday, 9:00-17:30 (GMT+8), closed on holidays
Scan to open our site

Scan to open our site

Home
Products
Contact
Search